US to distribute 6.4 million doses of Pfizer-BioNTech COVID-19 vaccine in first tranche by year-end

The federal government will issue recommendations for who should be prioritised — likely the elderly, high-risk, and frontline workers — but local authorities will make the final call

Agence France-Presse November 25, 2020 11:37:03 IST
US to distribute 6.4 million doses of Pfizer-BioNTech COVID-19 vaccine in first tranche by year-end

Pfizer vaccines distributed in the US will come from its largest manufacturing plant located in Kalamazoo, Michigan. AFP

Washington: The United States plans to distribute 6.4 million doses of the Pfizer-BioNTech COVID-19 vaccine in the first week after it is cleared for emergency use, which is likely next month, officials said Tuesday.

A committee of the Food and Drug Administration will meet on 10 December to decide whether to green light the medicine.

Latest figures on Tuesday showed that the country had recorded a total of 259,600 COVID-19 deaths and 12.5 million cases — with over 2,000 deaths and 167,000 new cases in just the last 24 hours.

General Gustave Perna, chief operations officer for the government's Operation Warp Speed, told reporters some 40 million doses of vaccine would be available by the end of December.

That figure includes another vaccine developed by Moderna and the National Institutes for Health, which announced some preliminary efficacy results last week and is also close to applying for emergency approval.

The Pfizer vaccine has ultra-cold long-term storage requirements of -70 degrees Celsius, and the company has developed special containers with dry ice to keep it cool for up to 15 days.

Perna said that 64 jurisdictions across the US — including the 50 states, territories like the capital Washington and Puerto Rico and Indian reservations — received their allocation numbers on Friday.

The amount they receive will be proportionate to their population size.

The federal government will issue recommendations for who should be prioritized — likely the elderly, high-risk, and frontline workers — but local authorities will make the final decision for themselves.

Vaccinations will begin in retirement homes within 48 hours of the emergency approval, health secretary Alex Azar said. The government has partnered with CVS Health for the retirement home program.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Coronavirus News Updates: UK approves Moderna's COVID-19 vaccine, pre-orders 7 mn doses
Health

Coronavirus News Updates: UK approves Moderna's COVID-19 vaccine, pre-orders 7 mn doses

Coronavirus News LIVE Updates: In trials with more than 30,000, the Moderna vaccine offered nearly 95 percent protection from severe COVID-19

Coronavirus News Updates: Eight UK returnees in Maharashtra infected with new COVID-19 strain, says Rajesh Tope
India

Coronavirus News Updates: Eight UK returnees in Maharashtra infected with new COVID-19 strain, says Rajesh Tope

Coronavirus News Updates: Of the eight, five are from Mumbai and one each from Pune, Thane and Mira Bhayandar. The contact tracing of these patients is going on, the state health minister said

All Indian vaccines being developed for storage at 2-8 degree Celsius, says DBT Secy
India

All Indian vaccines being developed for storage at 2-8 degree Celsius, says DBT Secy

Unlike the Pfizer and Moderna which requires a minus 70 degree Celsius (cold) chain, most Indian vaccine candidates have been designed to work at storage temperatures of 2-8 degrees Celsius due to logistical issues